Publisher
Springer International Publishing
Reference77 articles.
1. Alhusayen RO, Juurlink DN, Mamdani MM, Morrow RL, Shear NH, Dormuth CR. Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study. J Invest Dermatol. 2013;133(4):907–12. doi: 10.1038/jid.2012.387 .
2. Alikhan A, Griffin J, Nguyen N, Davis DM, Gibson LE. Pediatric follicular mucinosis: presentation, histopathology, molecular genetics, treatment, and outcomes over an 11-year period at the Mayo Clinic. Pediatr Dermatol. 2013;30(2):192–8. doi: 10.1111/pde.12019 .
3. Amann PM, Susic M, Gluder F, Berger H, Krapf W, Loffler H. Alitretinoin (9-cis retinoic acid) is effective against pityriasis rubra pilaris: a retrospective clinical study. Acta Derm Venereol. 2014;95:329–31. doi: 10.2340/00015555-1928 .
4. Berman B, Perez OA, Konda S, Kohut BE, Viera MH, Delgado S, Zell D, Li Q. A review of the biologic effects, clinical efficacy, and safety of silicone elastomer sheeting for hypertrophic and keloid scar treatment and management. Dermatol Surg Off Publ Am Soc Dermatol Surg [et al]. 2007;33(11):1291–302. doi: 10.1111/j.1524-4725.2007.33280.x ; discussion 1302–1293.
5. Bershad S, Poulin YP, Berson DS, Sabean J, Brodell RT, Shalita AR, Kakita L, Tanghetti E, Leyden J, Webster GF, Miller BH. Topical retinoids in the treatment of acne vulgaris. Cutis. 1999;64(2 Suppl):8–20; quiz 21–23.